4524.T
MORISHITA JINTAN CO.,LTD.
スタンダード · 医薬品 · 医薬品 · JP
JPY 2,243.00
−0.04%Year over year
Reported trailing growth
- Revenue
- -0.6%
- EBITDA
- —
- EBIT
- -13.9%
- EPS
- +14.6%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.9%
- EBITDA
- —
- EPS
- +14.9%
Three-year CAGR
- Revenue
- +3.8%
- EBITDA
- +2.5%
- EBIT
- +6.7%
- Net income
- +8.5%
- EPS
- +8.4%
- Free cash flow
- -71.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026